The big news for Synthes is the $21.3 billion deal that made it a subsidiary of Johnson & Johnson this year. The Swiss orthopedics giant makes instruments, implants and biomaterials for the surgical fixation, correction and regeneration of bone and soft tissue and products to treat bone fractures (including metallic and osteobiological materials).
Home » Synthes